688382 益方生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-2.927-18.935-12.614-13.482-33.344
总资产报酬率 ROA (%)-2.685-17.484-11.766-12.593-30.718
投入资产回报率 ROIC (%)-2.880-18.640-12.326-13.184-32.699

边际利润分析
销售毛利率 (%)96.17286.54397.675100.000--
营业利润率 (%)-104.036-849.091-142.309-153.064--
息税前利润/营业总收入 (%)-114.449-909.756-160.553-171.402--
净利润/营业总收入 (%)-104.289-849.742-142.309-153.064--

收益指标分析
经营活动净收益/利润总额(%)97.40999.888100.447100.12799.987
价值变动净收益/利润总额(%)-1.626-1.071-0.541-2.3100.000
营业外收支净额/利润总额(%)0.0000.0010.0000.0000.037

偿债能力分析
流动比率 (X)17.36011.08920.78413.41420.407
速动比率 (X)17.36011.08920.78413.41420.407
资产负债率 (%)6.5799.8445.7287.6165.661
带息债务/全部投入资本 (%)0.4580.4270.3982.6850.519
股东权益/带息债务 (%)21,485.42723,028.98424,778.2933,612.72618,978.022
股东权益/负债合计 (%)1,420.076915.8241,645.6581,213.0981,666.552
利息保障倍数 (X)10.99114.9998.8009.34714.381

营运能力分析
应收账款周转天数 (天)224.4301,206.808364.614342.611--
存货周转天数 (天)0.0000.0000.000----